• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Arcoma

8.94 SEK

+1.13 %

Less than 1K followers

ARCOMA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.13 %
+3.23 %
+3.00 %
+21.80 %
+24.86 %
-5.30 %
-8.78 %
-52.32 %
-32.88 %

Arcoma operates in the medical technology sector. The company is a developer and supplier of integrated digital X-ray systems. The company's products offer digital imaging technology combined with technically advanced mobile positioning systems. The products are sold through resellers and to a large proportion of OEM customers. Operations are found on a global level with sales primarily concentrated in Europe, Asia and North America. The head office is located in Växjö.

Read more
Market cap
127.92M SEK
Turnover
33.43K SEK
Revenue
130.8M
EBIT %
4.77 %
P/E
25.54
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
20/8
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release4 hours ago

Arcoma AB byter Certified Adviser till Tapper Partners AB

Arcoma
Regulatory press release6/9/2026, 10:00 AM

Arcoma utser Göran Edwall till interim CFO

Arcoma
Regulatory press release5/20/2026, 1:00 PM

Kommuniké från årsstämma i Arcoma Aktiebolag den 20 maj 2026

Arcoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/12/2026, 8:45 AM

CFO lämnar Arcoma under kvartal tre – rekrytering av efterträdare inledd

Arcoma
Regulatory press release5/11/2026, 9:45 AM

Arcoma AB erhåller order på 7 röntgensystem i USA värd ca 8 MSEK. (MAR)

Arcoma
Regulatory press release4/30/2026, 11:00 AM

Arcoma lanserar 3D-kamera med avancerat positioneringsstöd i Precision i5

Arcoma
Press release4/24/2026, 2:16 PM

DNB Carnegie Access: Arcoma: Market turmoil delays recovery – Q1 review

Arcoma
Regulatory press release4/23/2026, 6:30 AM

Kvartalsrapport Q1 2026. Positionerad för tillväxt med stark finansiell bas (MAR)

Arcoma
Regulatory press release4/21/2026, 1:00 PM

Arcoma AB utser Mattias Guldstrand till Chief Technology Officer

Arcoma
Regulatory press release4/14/2026, 10:00 AM

Årsredovisning för 2025 är nu publicerad

Arcoma
Regulatory press release4/10/2026, 1:30 PM

Rättelse: Kallelse till årsstämma i Arcoma Aktiebolag

Arcoma
Regulatory press release4/10/2026, 11:00 AM

Kallelse till årsstämma i Arcoma Aktiebolag (MAR)

Arcoma
Press release2/13/2026, 8:22 AM

DNB Carnegie Access: Arcoma: Going into 2026 with favourable comparables – Q4 review

Arcoma
Press release2/13/2026, 8:15 AM

DNB Carnegie Access: Arcoma - Q4 2025 - Rapportintervju

Arcoma
Regulatory press release2/12/2026, 7:30 AM

Bokslutskommuniké 2025 – Lönsamhet och kassaflöde skapar handlingsutrymme framåt (MAR)

Arcoma
Press release2/9/2026, 6:19 AM

DNB Carnegie Access: Arcoma: Awaiting a market recovery in Europe – Q4 preview

Arcoma
Press release10/24/2025, 6:02 AM

DNB Carnegie Access: Arcoma: Europe muted, business mix supports margins – Q3 review

Arcoma
Regulatory press release10/23/2025, 6:30 AM

Kvartalsrapport Q3 – 2025. Stark efterfrågan i USA, Europa påverkat av avvaktande marknad (MAR)

Arcoma
Press release10/13/2025, 4:52 PM

DNB Carnegie Access: Arcoma: Sequential improvements but US uncertainty – Q3 preview

Arcoma
Regulatory press release9/5/2025, 8:00 AM

Arcoma AB inför incitamentsprogram kopplat till aktieköp för ledning och andra ledande befattningshavare i företaget.

Arcoma